Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Health and Quality of Life Outcomes
|
August 24, 2019
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events
Shing M Lee, Jieling Miao, Ruby Wu, et al.
Cancer
|
November 8, 2017
Estimating global treatment toxicity burden from adverse-event data
Shing M Lee, Dawn L Hershman, Jieling Miao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2022
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Philip C Mack, Jieling Miao, Mary W Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study
Costanza Paoletti, Jieling Miao, Emily M Dolce, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 15, 2020
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
Darya A Kizub, Jieling Miao, Mark M Schubert, et al.
Clinical Lung Cancer
|
August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
Howard L West, James Moon, Antoinette J Wozniak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Martin J Edelman, Mary W Redman, Kathy S Albain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
Corey J Langer, Mary W Redman, James L Wade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2019
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
Anne S Tsao, Jieling Miao, Ignacio I Wistuba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Health and Quality of Life Outcomes
|
August 24, 2019
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events
Shing M Lee, Jieling Miao, Ruby Wu, et al.
Cancer
|
November 8, 2017
Estimating global treatment toxicity burden from adverse-event data
Shing M Lee, Dawn L Hershman, Jieling Miao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2022
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Philip C Mack, Jieling Miao, Mary W Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study
Costanza Paoletti, Jieling Miao, Emily M Dolce, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 15, 2020
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
Darya A Kizub, Jieling Miao, Mark M Schubert, et al.
Clinical Lung Cancer
|
August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
Howard L West, James Moon, Antoinette J Wozniak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Martin J Edelman, Mary W Redman, Kathy S Albain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)
Corey J Langer, Mary W Redman, James L Wade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2019
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
Anne S Tsao, Jieling Miao, Ignacio I Wistuba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2019
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Charu Aggarwal, Mary W Redman, Primo N Lara, et al.
Page
of 3